Cervical precancer is graded histologically as cervical intraepithelial neoplasia I (CIN I), CIN II or CIN III. e latter two grades are typically grouped together as high-grade CIN, which tends to develop into cancer without treatment [1] . e molecular basis of development of normal cervical squamous epithelia into cervical intraepithelial neoplasia and invasive carcinoma has not been completely elucidated.
Persistent infection by high-risk human papillomaviruses (HR-HPV), such as HPV18 and HPV16, is vital for the oncogenicity of cervical cells [2, 3] . E6 and E7 oncogenes of HR-HPV play critical roles in the development of the malignant phenotype of cervical cancer by interfering with the expression of tumor suppressor protein p53 [4] [5] [6] and retinoblastoma protein (pRb) [7] [8] [9] . e most common type-speci c HR-HPVs in Chinese women are HPV16, HPV52, HPV58, HPV33 and HPV18 [10] . In addition to persistent infection with HR-HPV, other host genetic changes and the dysregulated expression of various oncogenes and tumor suppressor genes also contribute to the development of cervical cancer.
GRIM-19 is associated with apoptosis [11] , growth inhibition [12] [13] [14] [15] [16] , migration, invasion and epithelialmesenchymal transition (EMT) [17] [18] [19] . Low GRIM-19 expression occurs in some human malignant tumors, such as those of the kidney, cervix, breast, liver and lung [14] [15] [20] [21] [22] [23] . GRIM-19 can suppress tumor growth by down-regulating STAT3-induced gene expression and inducing p53 accumulation through a disruption of the E6/E6AP complex and an induction of E6AP auto-ubiquitination in cervical cancerous cells [14, 21] . In the present study, the expression of GRIM-19, and its association with HR-HPV infection in malignant cervical exfoliated cells, was investigated further. GRIM-19 was found to gradually decrease from atypical squamous cells of undetermined signi cance (ASCUS), low-grade squamous intraepithelial lesion (LSIL) and high-grade squamous intraepithelial lesion (HSIL) to squamous cell carcinoma (SCC), and the reduced expression of GRIM-19 was positively correlated with HR-HPV infection.
Materials and Methods

Ethics Statement
is study was approved by the ethics review board of Anhui Provincial Hospital. Written consent was obtained from each patient.
Tissue specimen and exfoliated cells
e patients were selected from the gynecologic cytology practice at Anhui Provincial Hospital, which is a liated with Anhui Medical University in Hefei, China. e samples considered for this study included 40 slides of normal squamous cells, 40 slides of ASCUS, 40 slides of LSIL, 40 slides of HSIL and 20 slides of SCC from patients with cervical cancer. Cases were excluded if the patients were younger than 21 years, if the samples were obtained from women with previous hysterectomies, or if there was insu cient residual uid to extract cellular proteins. All Pap tests were collected in PreservCyte solution and processed using inPrep methodology (Hologic, Marlborough, MA, USA). All of the slides were screened by at least two certi ed cytotechnologists.
A total of 20 cases of normal cervical tissues, 35 cases of CIN I, 30 cases of CIN II, 30 cases of CIN III and 20 cases of SCC were used for the study. Colposcopy-directed biopsies were xed in 10% bu ered formalin and stained with hematoxylin and eosin using routine methods. e biopsies were included if they were obtained within three months of the abnormal Pap smear. All Pap smear slides and histological biopsy slides were reviewed by at least one experienced gynecologic pathologist who was also certi ed in cytopathology and were interpreted using established criteria. e Bethesda System was used for the cytological diagnosis, and the biopsies were reported using CIN terminology.
Immunohistochemistry and evaluation of immunoreactivity
e tissue sections were xed with 4% formaldehyde, dehydrated, embedded and cut into 2 μm serial sections. All Pap slides were used for the detection of GRIM-19 staining a er diagnosis by the experienced gynecologic pathologist. e slides were depara nized in xylene for 10 min, xed using 100% ethanol for 5 min and then dehydrated with graded ethanol. e endogenous peroxide activity was quenched by incubation with 3% hydrogen peroxide in methanol for 10 min.
e sections were washed twice with phosphate-bu ered saline (PBS) and incubated with the primary antibody for 2 hours at routine temperature. e samples were then rinsed twice with PBS and incubated with the corresponding secondary antibody for 30 min at 37°C. e sections were then washed with PBS and incubated for 1 min with a high-sensitivity substrate (DAB). Lastly, the slides were counterstained with 10% hematoxylin, and photographs were captured using a microscope with a digital camera.
Immunoreactivity in the tissue was evaluated independently by two pathologists who were blinded to the clinical data and other immunohistochemical results. Normal cervical tissues were used as a positive control. Negative controls were included in each slide assay (the omission of primary and secondary antibodies), and all controls yielded the appropriate results. Monoclonal antibodies against GRIM-19 (1:100) were purchased from Santa Cruz Biotechnology, and the secondary antibodies were obtained from Santa Cruz Biotechnology. e positive cells displayed brownish granules in the cytoplasm. Immunoreactivity was semi-quantitatively evaluated based on the staining intensity and the distribution using the immunoreactive score [24] : immunoreactive score = intensity score × proportion score. e intensity score was de ned as follows: 0, negative; 1, weak; 2, moderate; or 3, strong. e proportion score was de ned as follows: 0, negative; 1, <10%; 2, 11-50%; 3, 51-80%; or 4, >80% positive cells. e total score ranged from 0 to 12. e immunoreactivity was divided into three levels on the basis of the nal score, such that negative immunoreactivity was de ned as a total score of 0, low immunoreactivity was de ned as a total score of 1-4, and high immunoreactivity was de ned as a total score >4. e stained tumor tissues were scored by two researchers blinded to the clinical patient data.
Immunoblotting
Proteins were transferred to polyvinylidene uoride (PVDF) membranes and probed with monoclonal antibodies against GRIM-19 (1:1000). e membranes were then incubated with a 1:5000 dilution of a peroxidase-conjugated corresponding secondary antibody (Sigma, St. Louis, MO, USA). e blots were developed using an enhanced chemiluminescence kit (Pierce, ermo Scienti c, Northumberland, UK).
HPV DNA testing
DNA from the cervical tissues or cervical exfoliated cells was tested for the presence of HR-HPV DNA by the HC2 method according to the manufacturer's instructions (Digene Inc., Gaithersburg, MD, USA 
Statistical analysis
All statistical analyses were performed using the statistical package SPSS (Chicago, IL, USA), version 13. A P-value <0.05 was considered statistically signi cant.
Results
e expression of GRIM-19 in cervical exfoliated cells by immunohistochemistry
Cervical squamous epithelial tissue is generally composed of three layers: the surface layer (corni ed cells), middle layer and basal layer. e cervical exfoliated cells used for a Pap smear are mainly cells from the middle and surface layers. In the exfoliated cells, GRIM-19 was highly expressed in 94.2±2.8% (188.4±5.5/200) of the normal middle layer squamous cells (Fig. 1 a and a' ) and in 0±0.0% (0±0.00/200) of the normal surface layer squamous cells ( Fig. 1 b and b' between expression of G GRIM-19 and cytological diagnoses (χ 2 = 371.799 9, r = -0.616, highly signi cant correlation between GRIM-19 expression and the cytological diagnosis (P <0.001).
e expression of GRIM-19 in cervical exfoliated cells by Western blotting
GRIM-19 levels were further explored in cervical exfoliated cells by Western blotting. Because GRIM-19 was not expressed in the surface layer exfoliated cells, these cells were counted (as a percentage) on each slide. A er the GRIM-19/GAPDH proteins were quanti ed, the nal relative expression level of GRIM-19 was multiplied by the middle layer exfoliated cells/ (middle layer exfoliated cells+surface layer exfoliated cells)×100%, and GRIM-19/GAPDH in the normal middle layer exfoliated cells was normalized as 1. Decreased GRIM-19 expression was found in the LSIL, HSIL and SCC cells. Compared to the normal middle layer squamous cells, the expression of GRIM-19 was dramatically reduced in the LSIL cells (P <0.05), HSIL cells (P <0.05), and SCCs (P <0.001) (Fig. 3A-C ).
e expression of GRIM-19 and its association with HR-HPV infection in cervical precancers
As consistent HR-HPV infection is closely associated with SCC, the correlation of HR-HPV infection with the expression of GRIM-19 was explored in exfoliated cells. ere was a highly signi cant correlation between the expression of GRIM-19 and HR-HPV infection (χ 2 = 57.583, r = -0.268, P <0.001) ( Table 2) .
GRIM-19 expression in cervical intraepithelial neoplasias and SCCs by immunohistochemistry
To con rm the results found in exfoliated cells, GRM-19 expression was investigated in CIN I, CIN II, CIN III and SCC (Fig. 4 A-E) . High cytoplasmic expression of GRIM-19 was found in 100% (20/20) of the middle and basal layer cells of the normal cervical epithelium.
e negative expression of GRIM-19 was found in 20.0% (7/35) of CIN I, 23.3% (7/30) of CIN II, 56.7% (17/30) of CIN III and 95% (19/20) of SCC. e staining scores showed that, compared to the normal tissue, the expression of GRIM-19 was signi cantly decreased in CIN II(P <0.05)), CIN III(P <0.05) and SCC (P <0.001) (Fig. 4F) .
Discussion e basal layer of the normal cervix is considered to be composed of stem-like cells that can di erentiate into keratinocytes in the upper stratum of the epithelium. Once cell cycle arrest occurs, most basal cells will enter into terminal di erentiation and die by apoptosis [25] . In epidermal keratinocytes, terminal di erentiation and corni cation is a specialized form of apoptosis [26] [27] ; thus, the disturbance of normal corni cation through the loss of the ability to di erentiate can lead to ma- lignant squamous cell transformation [28] [29] . In this study, GRIM-19 was found to be predominantly expressed in the cytoplasm of the middle layer of the cervix and also in the basal layer, although it was completely absent in the surface layer of the cervix. ese ndings imply that the expression of GRIM-19 might contribute to the di erentiation of normal middle and basal layer cervical epithelia. Once the expression of GRIM-19 is reduced, the cells of these layers will advance toward abnormal di erentiation and enter into the cell cycle for proliferation.
CINs are now formally is classi ed as LSIL (CIN I) and HSIL (CIN II-III). e large majority of CIN I will spontaneously regress to normal or ASCUS within 6 to 12 months [30] [31] , and approximately 13% of women with a diagnosis of LSIL will develop an HSIL in 3 years [32] [33] . In our study, expression levels and percentages of GRIM-19 were found to gradually decrease from ASCUS, LSIL, HSIL to SCC. ese data suggest that CINs might regress a er the restoration of GRIM-19 expression using interferon and retinoids, which are also used for anti-viral infection in cervical pre-cancers .
e positive correlation between decreased GRIM-19 expression and HR-HPV infection suggests that GRIM-19 might be an important protein, preventing cervical cells from malignant transformation, and that the decrease in GRIM-19 might be the result of HR-HPV infection. e exact molecular events that mediate the reduction of GRIM-19 expression in NOTE: ere was a highly signi cant correlation between express sion of GRIM-19 and biopsy sy diagnoses (χ 2 = 95.550, r = = -0.646, P<0.001).
